BioGaia AB announced that Isabelle Ducellier, Chief Executive Officer has announced that she has decided to resign from the company and take on the role as Chief Executive Officer of Orkla portfolio company Orkla Health. Isabelle Ducellier will remain in her role until September 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
124.8 SEK | -0.16% | +9.38% | +23.32% |
May. 07 | Nordic Shares Closed Up Tuesday; Storskogen Group Series B Topped Leaders | DJ |
May. 07 | Transcript : BioGaia AB, Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.32% | 1.16B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-41.29% | 11.89B | |
-15.50% | 11.91B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- BIOG B Stock
- News BioGaia AB
- Isabelle Ducellier, Chief Executive Officer Decides to Resign from BioGaia AB